ENTA - Enanta Pharma EPS beats by $0.16 misses on revenue August, 05 2021 04:02 PM Enanta Pharmaceuticals Inc. Enanta Pharma (NASDAQ:ENTA): Q3 GAAP EPS of -$1.19 beats by $0.16. Revenue of $21.6M (+15.8% Y/Y) misses by $0.24M. Press Release For further details see: Enanta Pharma EPS beats by $0.16, misses on revenue